Drugs Made In America Acquisition Corp. (DMAA, DMAAR, DMAAU)

CIK 2028614 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Drugs Made In America Acquisition Corp..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0001604488-26-000087
Aug 14, 2026SCHEDULE 13G/A0001072613-26-000664
Aug 14, 202610-Q0001213900-26-090035
Aug 13, 2026SCHEDULE 13G/A0001076809-26-000079
Aug 13, 2026SCHEDULE 13G/A0001104659-26-095396
Jul 20, 20268-K0001213900-26-079678
Jul 20, 20264250001213900-26-079686
Jun 26, 2026SCHEDULE 13G0001376474-26-000460
May 14, 2026SCHEDULE 13G0001104659-26-060643
May 14, 202610-Q0001213900-26-056798
May 5, 20264250001213900-26-052331
May 5, 20268-K0001213900-26-052324
May 1, 20268-K0001213900-26-051018
Apr 28, 20268-K0001213900-26-048585
Apr 16, 2026DEFR14A0001213900-26-044631
Apr 15, 202610-K0001213900-26-044139
Apr 14, 2026DEF 14A0001213900-26-043527
Apr 8, 20268-K0001213900-26-041284
Apr 1, 2026NT 10-K0001213900-26-038499
Mar 27, 20268-K0001213900-26-035502
Mar 27, 2026PRE 14A0001213900-26-035624
Mar 6, 20268-K0001213900-26-024762
Mar 6, 20268-K0001213900-26-024392
Nov 18, 20258-K0001213900-25-111704
Nov 18, 202510-Q0001213900-25-112096